Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection.

By S. Smalley, J. Benedetti, D. Haller, S. Hundahl, N. C. Estes, J. Ajani, L. Gunderson, B. Goldman, J. Martenson, J. Jessup and 3 more. Journal of Clinical Oncology, 2012

795 citations recorded by the source corpus.

Subfields: Gastroenterology, Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/90cc229604dbe2c533272b267842cbc0db69a927

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. M. Malvezzi
2. E. Smyth
3. A. Ferro
4. A. Cervantes
5. D. Arnold
6. B. Peleteiro
7. F. Levi
8. P. Bertuccio

Citations in the corpus

• Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2010, background): “After 10 years of follow-up, this OS improvement remains significant [I, A] [40].”
• Worldwide trends in gastric cancer mortality (1980-2011), with predictions to 2015, and incidence by subtype. (2014, background): “The gradual improvements in gastric cancer diagnosis – new endoscopy and staging techniques, such as computerised tomography scanning, endoscopic ultrasound – and treatment – introduction of chemoradiotherapy after surgery [44], perioperative chemotherapy [45], new molecularly targeted therapy for b”